Guggenheim Downgrades Allergen (AGN) to Neutral on Takeover
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- US stock futures steady after tech slump; investors focus on Middle East tensions
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- U.S. debt tops $40 trillion
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Marvell shares jump after giving Google warrants amid custom chip deal
Ackman Will Withdraw Request for Special Allergan (AGN) Meeting - CNBC
November 18, 2014 10:24 AM ESTPershing Squares Bill Ackman says he's withdrawing his request for a special Allergan (NYSE: AGN) meeting, according to CNBC.
... MoreWells Fargo Downgrades Allergen (AGN) to Market Perform
November 18, 2014 8:00 AM ESTWells Fargo downgraded Allergen (NYSE: AGN) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreSunTrust Downgrades Allergen (AGN) to Neutral
November 18, 2014 6:39 AM ESTSunTrust Robinson Humphrey downgraded Allergen (NYSE: AGN) from Buy to Neutral.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreWilliam Blair Downgrades Allergen (AGN) to Market Perform
November 18, 2014 6:38 AM ESTWilliam Blair downgraded Allergen (NYSE: AGN) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Allergen click here. For more ratings news on Allergen click here.
Shares of Allergen closed at $209.20 yesterday.
... MoreActavis (ACT) Agrees to Acquire Allergan (AGN) for ~$219/Share
November 17, 2014 9:15 AM EST(Updated - November 17, 2014 9:16 AM EST)
Actavis plc (NYSE: ACT) and Allergan, Inc. (NYSE: AGN) announced that they have entered into a definitive agreement under which Actavis will acquire Allergan for a combination of $129.22 in cash and 0.3683 Actavis shares for each share of Allergan common stock. Based on the closing price of Actavis shares on November 14, 2014, the transaction is valued at approximately $66 billion, or $219 per Allergan share. The combination will create one of the top 10 global pharmaceutical companies by sales revenue, with combined annual pro forma revenues of more than... More
